AOS26 Bevacizumab-induced hypertension and use of anti-hypertensive drugs is associated with improved outcome in patients with solid organ tumours treated with bevacizumab

2012 ◽  
Vol 48 ◽  
pp. S12
Author(s):  
C.S. Tan ◽  
W. Ling ◽  
T. Soh ◽  
A. Pang ◽  
P.J. Voon ◽  
...  
Keyword(s):  
Solid Organ ◽  
Induced Hypertension ◽  
Improved Outcome ◽  
Solid Organ Tumours

scholarly journals An extremely rare case of testicular malign neoplasm; alveolar subtype of rhabdomyosarcoma with long term follow-up.

2014 ◽  
Vol 4 (2) ◽  
pp. 134-135
Author(s):  
Tumay Ipekci ◽  
Yigit Akin ◽  
Burak Hoscan ◽  
Ahmet Tunckiran
Keyword(s):  
Germ Cell ◽  
Rare Case ◽  
Clinical Findings ◽  
Testicular Neoplasm ◽  
Solid Organ ◽  
Germ Cell Tumours ◽  
Long Term Follow Up ◽  
Solid Organ Tumours

Testicular neoplasm usually occur in men aged between 15 and 35. These are solid organ tumours and also should be operated when there is a suspicious clinical findings. Testis tumours are levelled after histopathology evaluation. The medical, surgical and follow-up strategies of well know testis tumours, such as seminomas, non-seminom germ cell tumours, have been established. In case of testis tumours rare entities may occur as rhabdomyosarcoma.We here presented a rare case of   alveolar subtype of rhabdomyosarcoma in testis with long term follow-up.

scholarly journals Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response

2020 ◽  
Vol 86 (9) ◽  
pp. 1736-1752 ◽  
Author(s):  
Vishal Navani ◽  
Moira C. Graves ◽  
Nikola A. Bowden ◽  
Andre Van Der Westhuizen
Keyword(s):  
Immune Checkpoint ◽  
Immune Checkpoint Blockade ◽  
Checkpoint Blockade ◽  
Solid Organ ◽  
Predictors Of Response ◽  
Solid Organ Tumours

scholarly journals Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results

2020 ◽  
Vol 58 (3) ◽  
pp. 528-536 ◽  
Author(s):  
Andrea Garatti ◽  
Mariangela D’Ovidio ◽  
Guglielmo Saitto ◽  
Andrea Daprati ◽  
Alberto Canziani ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Survival Rate ◽  
Cardiovascular Events ◽  
Artery Bypass ◽  
Major Adverse Cardiovascular Events ◽  
Consecutive Series ◽  
Solid Organ ◽  
Bypass Grafting ◽  
Solid Organ Tumours

Abstract OBJECTIVES Our goal was to analyse a consecutive series of patients with solid organ tumours undergoing coronary artery bypass grafting (CABG) by defining the risk factors for early and long-term outcomes. METHODS Between 2005 and 2016, a consecutive series of 4079 patients underwent isolated CABG at our institution. Of 103 patients (2.5%) with active malignancy, we enrolled 82 patients (mean age 71 ± 7 years) with solid organ tumours, divided into 4 subgroups: lung (9 patients—11%), gastroenteric (16 patients—20%), urinary (48 patients—58%) and other solid tumours (9 patients—11%). A deterministic record linkage between the clinical database and the National Hospital Information System allowed identification of long-term survival rates and freedom from major adverse cardiovascular events (acute myocardial infarction, repeated admissions for percutaneous coronary intervention and heart failure). RESULTS The most common forms of cancer were prostate, colon and carcinoma of the lung. Compared to patients without cancer, patients with neoplasms were significantly older and had a higher rate of comorbidities, without significant differences among the cancer subgroups. The 30-day mortality rate was significantly higher in patients with cancer compared to those without cancer (4.9% vs 1.8%). However, on logistic regression analysis, cancer was an independent risk factor for postoperative pulmonary dysfunction but not for in-hospital death. The median follow-up time was 58 ± 12 months. The overall 5-year survival rate was 60% [95% confidence interval (CI) 47–71%], with a dismal 32% (95% CI 5–65%) survival rate among patients who had lung tumours only. The 5-year freedom from major adverse cardiovascular events was 64% (95% CI 52–74%), without significant differences among subgroups, and was comparable to that of the non-cancer population. Resolution of coronary heart disease allowed safe cancer surgical resection in 80% of the population. CONCLUSIONS Based on the results from the present study, CABG should not be denied to patients with solid organ tumours by claiming a worse prognosis or less graft durability. Further studies with larger numbers are warranted.

Sign in / Sign up

Export Citation Format

Share Document